The aim of our work was to evaluate the feasibility of in vivo single-voxel quantitative proton MR spectroscopy in order to identify possible alterations in the main metabolite concentrations due to some metabolic dysfunctions in the cerebellum of patients suffering from a particular form of migraine called “with aura.” Measurements of metabolite levels in the cerebellum disclosed reduced choline values (normalized both to N-acetyl-aspartate and creatine) in the patient group with respect to the age-matched control group. Our interest in this pathology is motivated by the fact that there are no available specific biochemical markers for migraine characterization, and the current diagnostic only takes advantage of the medical history and the clinical examination
Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy / Macri', MARIA ANTONIETTA; G., Garreffa; Giove, Federico; A., Ambrosini; M., Guardati; Pierelli, Francesco; J., Schoenen; Colonnese, Claudio; Maraviglia, Bruno. - In: MAGNETIC RESONANCE IMAGING. - ISSN 0730-725X. - 21:10(2003), pp. 1201-1206. (Intervento presentato al convegno International School on Magnetic Resonance and Brain Function tenutosi a ERICE, ITALY nel APR 06-10, 2003) [10.1016/j.mri.2003.08.021].
Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy
MACRI', MARIA ANTONIETTA;GIOVE, FEDERICO;PIERELLI, Francesco;COLONNESE, Claudio;MARAVIGLIA, Bruno
2003
Abstract
The aim of our work was to evaluate the feasibility of in vivo single-voxel quantitative proton MR spectroscopy in order to identify possible alterations in the main metabolite concentrations due to some metabolic dysfunctions in the cerebellum of patients suffering from a particular form of migraine called “with aura.” Measurements of metabolite levels in the cerebellum disclosed reduced choline values (normalized both to N-acetyl-aspartate and creatine) in the patient group with respect to the age-matched control group. Our interest in this pathology is motivated by the fact that there are no available specific biochemical markers for migraine characterization, and the current diagnostic only takes advantage of the medical history and the clinical examinationI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
